Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04964557
What this trial is testing

Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia

Who this might be right for
Hyperlipidaemia
AstraZeneca 411
Early research (Phase 1)Study completedNCT06597799
What this trial is testing

First-in-human Study of MRT-6160 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Monte Rosa Therapeutics, Inc 108
Early research (Phase 1)Study completedNCT01276119
What this trial is testing

The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males

Who this might be right for
Pharmacokinetics
UCB Pharma 67
Testing effectiveness (Phase 2)Study completedNCT04823611
What this trial is testing

AZD8233 in Participants With Dyslipidemia.

Who this might be right for
Dyslipidemia
AstraZeneca 87
Large-scale testing (Phase 3)Active Not RecruitingNCT05208281
What this trial is testing

A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II

Who this might be right for
Mucopolysaccharidosis Type IIMetabolic Diseases
AO GENERIUM 32
Early research (Phase 1)Study completedNCT01343498
What this trial is testing

Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumour
SCRI Development Innovations, LLC 33
Early research (Phase 1)UnknownNCT05863442
What this trial is testing

Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants

Who this might be right for
Healthy
Turgut Ardika PTY LTD 120
Early research (Phase 1)Active Not RecruitingNCT07350577
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants

Who this might be right for
Ulcerative Colitis (UC)
AltruBio Inc. 24
Early research (Phase 1)Study completedNCT06548945
What this trial is testing

A Phase I Study of GZR18 Injection in Obese/Overweight Subjects

Who this might be right for
Overweight and Obesity
Gan and Lee Pharmaceuticals, USA 16
Early research (Phase 1)Study completedNCT07708831
What this trial is testing

Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Clarent Biopharma, Inc. 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT07074977
What this trial is testing

Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)

Who this might be right for
Chronic Pruritus of Unknown Origin
Galderma R&D 50
Large-scale testing (Phase 3)Study completedNCT02820987
What this trial is testing

PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock

Who this might be right for
Septic Shock
Centre Hospitalier Universitaire de Besancon 119
Early research (Phase 1)Study completedNCT03316521
What this trial is testing

First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers

Who this might be right for
Complement Mediated Diseases
Amyndas Pharmaceuticals S.A. 50
Early research (Phase 1)Study completedNCT04467684
What this trial is testing

Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406

Who this might be right for
Healthy Volunteers
Gilead Sciences 90
Testing effectiveness (Phase 2)Study completedNCT00088582
What this trial is testing

Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 62
Early research (Phase 1)Study completedNCT04036227
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-248

Who this might be right for
Healthy
Gesynta Pharma AB 72
Early research (Phase 1)Looking for participantsNCT07352423
What this trial is testing

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN2230 in Healthy Participants

Who this might be right for
Healthy Adult Participants
Alexion Pharmaceuticals, Inc. 48
Early research (Phase 1)Study completedNCT03287310
What this trial is testing

First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma

Who this might be right for
Asthma
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Study completedNCT04037085
What this trial is testing

Ketamine to Improve Recovery After Cesarean Delivery - Part 1

Who this might be right for
Obstetric PainPostpartum DepressionBreastfeeding+5 more
Grace Lim, MD, MS 8
Early research (Phase 1)Study completedNCT00928343
What this trial is testing

First-in-Human Single Ascending Subcutaneous (s.c.) Dose and Single Oral Dose of GLPG0187

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 18
Next Page